
    
      Trial investigates whether Levodopa/Carbidopa compared to placebo given in addition to
      standardized rehabilitative therapy in patients with acute stroke is associated with

      a) patient relevant improvements of physical function b) improvement in patient-self assessed
      general health aspects, pain, mood, anxiety, fatigue and social participation c) long-term
      sustainability of a patient-relevant improvement of motor function d) improvement of
      selective hand and wrist movement e) a higher rate of patients walking independently of the
      help of another person.

      f) less severe impairment g) a higher level of activity of daily living h) improvements of
      quality of life (i) better cognitive performance (j) no signals of harms (i.e. indications
      for increased all-cause mortality, recurrent stroke or serious adverse events).
    
  